Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis

GINA fosters World Asthma Day 2020 to prevent asthma deaths

(2020) Louis-Philippe Boulet et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan

(2019) Hiroyuki Nagase et al.   ALLERGOLOGY INTERNATIONAL

‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up

(2018) M.M. Folqué et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Clinical and economic burden of severe asthma: A French cohort study

(2018) Clementine Nordon et al.   RESPIRATORY MEDICINE

Strategies to reduce corticosteroid-related adverse events in asthma

(2018) Enrico Heffler et al.   Current Opinion in Allergy and Clinical Immunology

Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study

(2016) Jing Li et al.   Allergy Asthma & Immunology Research

Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents

(2015) Gustavo J. Rodrigo et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma

(2013) Gilles Garcia et al.   CHEST

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Asthma Control in Patients with Persistent Allergic Asthma

(2012) Jose Bardelas et al.   JOURNAL OF ASTHMA

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

(2011) William W. Busse et al.   NEW ENGLAND JOURNAL OF MEDICINE

Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma

(2010) M. Kulus et al.   CURRENT MEDICAL RESEARCH AND OPINION

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations

(2009) Raymond G. Slavin et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma

(2009) Bob Lanier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effect of Long-term Corticosteroid Use on Bone Mineral Density in Children: A Prospective Longitudinal Assessment in the Childhood Asthma Management Program (CAMP) Study

(2008) H. W. Kelly et al.   PEDIATRICS